Reinventing radiation therapy with machine learning and imaging bio-markers (radiomics): State-of-the-art, challenges and perspectives

L Dercle, T Henry, A Carré, N Paragios, E Deutsch… - Methods, 2021 - Elsevier
Radiation therapy is a pivotal cancer treatment that has significantly progressed over the last
decade due to numerous technological breakthroughs. Imaging is now playing a critical role …

Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging

S Chen, S Feng, J Wei, F Liu, B Li, X Li, Y Hou, D Gu… - European …, 2019 - Springer
Objectives Immunoscore evaluates the density of CD3+ and CD8+ T cells in both the tumor
core and invasive margin. Pretreatment prediction of immunoscore in hepatocellular cancer …

Influence of Magnetic Field Strength on Magnetic Resonance Imaging Radiomics Features in Brain Imaging, an In Vitro and In Vivo Study

S Ammari, S Pitre-Champagnat, L Dercle… - Frontiers in …, 2021 - frontiersin.org
Background The development and clinical adoption of quantitative imaging biomarkers
(radiomics) has established the need for the identification of parameters altering radiomics …

Prediction of histologic neoadjuvant chemotherapy response in osteosarcoma using pretherapeutic MRI radiomics

A Bouhamama, B Leporq, W Khaled… - Radiology: Imaging …, 2022 - pubs.rsna.org
Histologic response to chemotherapy for osteosarcoma is one of the most important
prognostic factors for survival, but assessment occurs after surgery. Although tumor imaging …

The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI

L Rozenblum, FZ Mokrane, R Yeh, M Sinigaglia… - Abdominal …, 2019 - Springer
Pancreatic neuroendocrine tumors (pNETs) are rare neoplasms that secrete peptides and
neuro-amines. pNETs can be sporadic or hereditary, syndromic or non-syndromic with …

Use of precision imaging in the evaluation of pancreas cancer

RL Korn, S Rahmanuddin, E Borazanci - Precision Medicine in Cancer …, 2019 - Springer
Pancreas cancer is an aggressive and fatal disease that will become one of the leading
causes of cancer mortality by 2030. An all-out effort is underway to better understand the …

Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: a step-by-step approach

L Rozenblum, FZ Mokrane, R Yeh, M Sinigaglia… - European journal of …, 2020 - Elsevier
The majority of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are diagnosed
at a non-resectable stage due to non-specific clinical syndromes, late manifestations from …

3D brachytherapy for cervical cancer: New optimization ways

I Fumagalli, C Haie-Méder, C Chargari - Cancer/Radiothérapie, 2018 - Elsevier
Brachytherapy has known major improvements in recent decades. It represents an essential
component of local treatment of cervix cancers. One major breakthrough was the advent of …

[PDF][PDF] Фантомы в ядерной медицине

ПО Румянцев, АА Трухин, КА Сергунова… - Медицинская …, 2020 - researchgate.net
РефеРат Разработка фантомов для ядерной медицины основана на
последовательном описании вычислительной и экспериментальной биологических …

Prédiction de la réponse à la chimiothérapie des ostéosarcomes à partir des données radiomiques issues des IRM diagnostiques

J Dufau, A Bouhamama, B Leporq, L Malaureille… - Bulletin du …, 2019 - Elsevier
Résumé Introduction L'ostéosarcome est la tumeur osseuse maligne la plus fréquente avant
25 ans. La réponse à la chimiothérapie néo-adjuvante influe la suite du traitement et est un …